p-SCN-Bn-HEHA is a specialized chelator designed for stable binding with actinium, particularly suitable for radiotherapy applications. Its isothiocyanate (SCN) group enables efficient conjugation with primary amines on biomolecules, such as antibodies or peptides, facilitating targeted delivery in cancer treatments.
Applications:
- Actinium Radiotherapy: Strongly binds actinium-225 for targeted alpha-particle therapy.
- Targeted Conjugation: SCN group easily attaches to biomolecules for precise delivery.
- Molecular Imaging: Supports targeted imaging studies when labeled with compatible radiometals.
p-SCN-Bn-HEHA is essential in developing targeted radiotherapeutics, offering high stability and specific actinium binding.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
